Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293493573> ?p ?o ?g. }
- W4293493573 endingPage "2948" @default.
- W4293493573 startingPage "2937" @default.
- W4293493573 abstract "Pharmacokinetics (PK) of a drug drive its exposure, efficacy, and tolerability. A thorough preclinical PK assessment of antiseizure medications (ASMs) is therefore essential to evaluate the clinical potential. We tested protection against evoked seizures of prototype ASMs in conjunction with analysis of plasma and brain PK as a proof-of-principle study to enhance our understanding of drug efficacy and duration of action using rodent seizure models.In vivo seizure protection assays were performed in adult male CF-1 mice and Sprague Dawley rats. Clobazam (CLB), N-desmethyl CLB (NCLB), carbamazepine (CBZ), CBZ-10,11-epoxide (CBZE), sodium valproate (VPA), and levetiracetam (LEV) concentrations were quantified in plasma and brain using liquid chromatography-tandem mass spectrometry. Mean concentrations of each analyte were calculated and used to determine PK parameters via noncompartmental analysis in Phoenix WinNonLin.NCLB concentrations were approximately 10-fold greater than CLB in mice. The antiseizure profile of CLB was partially sustained by NCLB in mice. CLB concentrations were lower in rats than in mice. CBZE plasma exposures were approximately 70% of CBZ in both mice and rats, likely contributing to the antiseizure effect of CBZ. VPA showed a relatively short half-life in both mice and rats, which correlated with a sharp decline in efficacy. LEV had a prolonged brain and plasma half-life, associated with a prolonged duration of action in mice.The study demonstrates the utility of PK analyses for understanding the seizure protection time course in mice and rats. The data indicate that distinct PK profiles of ASMs between mice and rats likely drive differences in drug efficacy between rodent models." @default.
- W4293493573 created "2022-08-29" @default.
- W4293493573 creator A5001492458 @default.
- W4293493573 creator A5018948189 @default.
- W4293493573 creator A5052368478 @default.
- W4293493573 creator A5058797510 @default.
- W4293493573 creator A5068483461 @default.
- W4293493573 creator A5071806289 @default.
- W4293493573 date "2022-09-11" @default.
- W4293493573 modified "2023-09-26" @default.
- W4293493573 title "Evaluating the efficacy of prototype antiseizure drugs using a preclinical pharmacokinetic approach" @default.
- W4293493573 cites W1506294480 @default.
- W4293493573 cites W1964465959 @default.
- W4293493573 cites W1969760382 @default.
- W4293493573 cites W1970580718 @default.
- W4293493573 cites W1995998505 @default.
- W4293493573 cites W1996135664 @default.
- W4293493573 cites W2014281284 @default.
- W4293493573 cites W2017398416 @default.
- W4293493573 cites W2020426939 @default.
- W4293493573 cites W2021307447 @default.
- W4293493573 cites W2021845665 @default.
- W4293493573 cites W2021998319 @default.
- W4293493573 cites W2026503251 @default.
- W4293493573 cites W2026755538 @default.
- W4293493573 cites W2031062317 @default.
- W4293493573 cites W2035450232 @default.
- W4293493573 cites W2041295849 @default.
- W4293493573 cites W2042706869 @default.
- W4293493573 cites W2056098510 @default.
- W4293493573 cites W2057802344 @default.
- W4293493573 cites W2058518177 @default.
- W4293493573 cites W2060645072 @default.
- W4293493573 cites W2072985875 @default.
- W4293493573 cites W2075474022 @default.
- W4293493573 cites W2086516145 @default.
- W4293493573 cites W2086759170 @default.
- W4293493573 cites W2090692462 @default.
- W4293493573 cites W2094089029 @default.
- W4293493573 cites W2100283245 @default.
- W4293493573 cites W2134634156 @default.
- W4293493573 cites W2142552421 @default.
- W4293493573 cites W2161161622 @default.
- W4293493573 cites W2163462721 @default.
- W4293493573 cites W2397673134 @default.
- W4293493573 cites W2408545542 @default.
- W4293493573 cites W2493372935 @default.
- W4293493573 cites W2497895645 @default.
- W4293493573 cites W2609313476 @default.
- W4293493573 cites W2614077129 @default.
- W4293493573 cites W2777270043 @default.
- W4293493573 cites W2793658169 @default.
- W4293493573 cites W2894629605 @default.
- W4293493573 cites W2911761011 @default.
- W4293493573 cites W2973225802 @default.
- W4293493573 cites W3027251650 @default.
- W4293493573 cites W3095034769 @default.
- W4293493573 cites W3210244522 @default.
- W4293493573 cites W4211147755 @default.
- W4293493573 cites W74649421 @default.
- W4293493573 doi "https://doi.org/10.1111/epi.17402" @default.
- W4293493573 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36054499" @default.
- W4293493573 hasPublicationYear "2022" @default.
- W4293493573 type Work @default.
- W4293493573 citedByCount "1" @default.
- W4293493573 countsByYear W42934935732023 @default.
- W4293493573 crossrefType "journal-article" @default.
- W4293493573 hasAuthorship W4293493573A5001492458 @default.
- W4293493573 hasAuthorship W4293493573A5018948189 @default.
- W4293493573 hasAuthorship W4293493573A5052368478 @default.
- W4293493573 hasAuthorship W4293493573A5058797510 @default.
- W4293493573 hasAuthorship W4293493573A5068483461 @default.
- W4293493573 hasAuthorship W4293493573A5071806289 @default.
- W4293493573 hasBestOaLocation W42934935732 @default.
- W4293493573 hasConcept C112705442 @default.
- W4293493573 hasConcept C118552586 @default.
- W4293493573 hasConcept C185592680 @default.
- W4293493573 hasConcept C197934379 @default.
- W4293493573 hasConcept C2775858608 @default.
- W4293493573 hasConcept C2777332695 @default.
- W4293493573 hasConcept C2778186239 @default.
- W4293493573 hasConcept C2778375690 @default.
- W4293493573 hasConcept C2779253243 @default.
- W4293493573 hasConcept C2780035454 @default.
- W4293493573 hasConcept C71924100 @default.
- W4293493573 hasConcept C98274493 @default.
- W4293493573 hasConceptScore W4293493573C112705442 @default.
- W4293493573 hasConceptScore W4293493573C118552586 @default.
- W4293493573 hasConceptScore W4293493573C185592680 @default.
- W4293493573 hasConceptScore W4293493573C197934379 @default.
- W4293493573 hasConceptScore W4293493573C2775858608 @default.
- W4293493573 hasConceptScore W4293493573C2777332695 @default.
- W4293493573 hasConceptScore W4293493573C2778186239 @default.
- W4293493573 hasConceptScore W4293493573C2778375690 @default.
- W4293493573 hasConceptScore W4293493573C2779253243 @default.
- W4293493573 hasConceptScore W4293493573C2780035454 @default.
- W4293493573 hasConceptScore W4293493573C71924100 @default.
- W4293493573 hasConceptScore W4293493573C98274493 @default.